Should I buy National Health Investors, Inc. (NHI) stock or is it too late?

National Health Investors, Inc. · Real Estate · price $73

See the full National Health Investors, Inc. (NHI) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Deutsche Bank — 74% of its targets hit on this sector (46 calls tested). It aims for $80 (+10 %), call made on June 26, 2026, maturing on June 26, 2027 (63 d ago).

The 1 reliable analyst $80+10 %

The 4 other firms $80.50+11 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $80 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on National Health Investors, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
BMO Capital	33 %	-2.4 %	6	$80 +10%
Keybanc	20 %	-19.8 %	5	$88 +21%

In short — Should you invest in National Health Investors, Inc.? Is it too late, still worth it? Analysts are fairly positive (60% buy, median target $80, i.e. +10%), and the most reliable on NHI targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

60% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
Median price target $80, i.e. +10% from the current price ($73).
The most reliable firm on NHI, Wells Fargo (100% hit rate, 2 scored calls), targets $79 (call made on June 1, 2026, maturing on June 1, 2027) (+9%) in its most recent call, and $85 (call made on November 25, 2025, maturing on November 25, 2026) (+17%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 5 ratings, 2 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on NHI

Median target $80 (+10%) · 5 ratings · Buy consensus

Strong Buy00%

Buy360%

Hold240%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in National Health Investors, Inc. now?

We won't decide for you. The facts: 60% of analysts rate it a buy, median target $80 (+10%), and Wells Fargo (most reliable on NHI, 100%) targets $79. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in National Health Investors, Inc.?

Not according to analysts: the median target ($80) is still +10% above the current price ($73) (most reliable on NHI: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is National Health Investors, Inc. still worth investing in?

It depends on the gap between the price ($73) and its estimated value: analysts target $80 on median (+10%), with 60% buys (most reliable on NHI: Wells Fargo, 100%). Cross-check with their real reliability on NHI and the cautions above. Information, not advice.

What's the main risk in buying NHI?

The consensus is not unanimous: of 5 ratings, 2 are neutral.

→ Go deeper: the full National Health Investors, Inc. profile (consensus, analyst reliability, price target, performance).